ArticleBMC genomics2025
A systematic longitudinal study of microbiome: integrating temporal-spatial dimensions with causal and deep learning models.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pulmonary lesions reshape swine respiratory microbiota: evidence of bacterial dysbiosis and reduced diversity.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- The impact of gut microbiota on cervical cancer and precancerous lesions: neglected status, mechanisms, challenges, and a call to action.Frontiers in immunology · 2026Review
- The microbiome-gerogene axis: a new frontier in precision geromedicine.Frontiers in aging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Longitudinal microbiome data provide a unique opportunity to explore dynamic interactions between microbial communities and disease progression. However, these data are often characterized by missing values, sparse signals, and limited interpretability, which impede effective biomarker discovery and accurate disease modeling. Therefore, we propose SysLM, a comprehensive deep learning framework for systematic analysis of longitudinal microbiome data. It comprises two synergistic modules: SysLM-I and SysLM-C. SysLM-I focuses on the task of missing-value inference, combines metadata and three feature enhancement strategies, and comprehensively captures temporal causality and long-term dependence through Temporal Convolutional Network and Bi-directional Long Short-Term Memory modules. SysLM-C integrates deep learning with causal inference modeling to construct three causal spaces to accomplish the tasks of classification and screening of multiple types of biomarkers, including differential biomarkers of microbiomes, network biomarkers, core biomarkers, dynamic biomarkers, disease-specific biomarkers, and shared biomarkers. SysLM demonstrates superior performance in imputation, classification, and biomarker discovery across multiple datasets. Importantly, it uncovers novel microbial mechanisms underlying ulcerative colitis, highlighting its value for precision medicine. By integrating deep learning with causal modeling, SysLM offers a promising approach to advance microbiome-based disease research and facilitate the development of targeted therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.